Cargando…
Osteopontin Upregulates the Expression of Glucose Transporters in Osteosarcoma Cells
Osteosarcoma is the most common primary malignancy of bone. Even after the traditional standard surgical therapy, metastasis still occurs in a high percentage of patients. Glucose is an important source of metabolic energy for tumor proliferation and survival. Tumors usually overexpress glucose tran...
Autores principales: | Hsieh, I-Shan, Yang, Rong-Sen, Fu, Wen-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195676/ https://www.ncbi.nlm.nih.gov/pubmed/25310823 http://dx.doi.org/10.1371/journal.pone.0109550 |
Ejemplares similares
-
Osteopontin as a biomarker for osteosarcoma therapy and prognosis
por: Han, Xingwen, et al.
Publicado: (2019) -
Osteopontin Is Upregulated in Human and Murine Acute Schistosomiasis Mansoni
por: Pereira, Thiago Almeida, et al.
Publicado: (2016) -
The inhibition of in vivo tumorigenesis of osteosarcoma (OS)-732 cells by antisense human osteopontin RNA
por: Liu, Si-Jin, et al.
Publicado: (2007) -
The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis
por: Lavi, Hadas, et al.
Publicado: (2017) -
Interleukin-6 upregulates SOX18 expression in osteosarcoma
por: Wu, Zhong, et al.
Publicado: (2017)